Jens Juul Holst

Jens Juul Holst

Professor


  1. 2001
  2. Published

    Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

    Toft-Nielsen, M. B., Damholt, M. B., Madsbad, Sten, Hilsted, L. M., Hughes, T. E., Michelsen, B. K. & Holst, Jens Juul, 2001, In: Journal of Clinical Endocrinology and Metabolism. 86, 8, p. 3717-3723 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Determinants of the effectiveness of glucagon-like peptide- 1 in type 2 diabetes

    Toft-Nielsen, M. B., Madsbad, S. & Holst, Jens Juul, 2001, In: J Clin Endocr Metab. 86, p. 3853-3860

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    PACAP 1-38 as neurotransmitter in the porcine antrum

    Tornoe, K., Hannibal, J., Georg, B. & Holst, Jens Juul, 2001, In: Regulatory Peptides. 101, p. 109-121

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Effect of glucagon-like peptide- 1 (7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes

    Vella, A., Shah, P., Basu, R. & Holst, Jens Juul, 2001, In: Diabetes. 50, p. 565-572

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction

    Verdich, C., Toubro, S., Buemann, B. & Holst, Jens Juul, 2001, In: International Journal of Obesity. 25, p. 1206-1214

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, Jens Juul, 1 Feb 2001, In: Diabetic Medicine. 18, 2, p. 144-149 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes

    Zander, M., Taskiran, M., Toft-Nielsen, M. B. & Holst, Jens Juul, 2001, In: Diabetes Care. 24, p. 720-725

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2000
  10. Published

    1,5-Anhydro fructose increase glucose tolerance by increasing GLP-1 and insulin in mice

    Ahrén, B., Holst, Jens Juul, Marcussen, J. & Yu, S., 2000, In: Eur. J. Pharmacol.. 397, p. 219-225

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Antidiabetogenic action of cholecystokinin in type 2 diabetes

    Ahrén, B., Holst, Jens Juul & Efendic, S., 2000, In: J. Clin. Endocrinol. Metab.. 85, p. 1043-8

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Improved glucagon tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice

    Ahrén, B., Holst, Jens Juul, Mårtensson, H. & Balkan, B., 2000, In: Eur. J. Pharmacol.. 404, p. 239-245

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207